Volume 18, Number 1
We are happy to share some hopeful and encouraging news regarding the situation in our region.
A ceasefire agreement has now been reached, and we are optimistic that this will bring an end to the conflict in the northern region of Israel.
Moreover, we believe this positive development will pave the way for a resolution and an end to the war in Gaza in the near future.
While Elcam has successfully maintained routine operations throughout the past year, this significant change reduces the need for many of the precautions we had implemented to ensure business continuity.
We are heartened to see that citizens in the northern border areas are beginning to return to their homes, a sign of renewed stability and normalcy in the region.
We are grateful for the resilience of our team and the unwavering support from our partners, which have been instrumental in navigating these challenging times.
We remain committed to delivering the quality, reliability, and service you expect from us, and we are hopeful that these recent developments mark the beginning of a more peaceful and stable future for all.
Thank you once again for your continued trust and partnership. If you have any questions or require further assistance, please don’t hesitate to reach out to us.
The demand for devices that enable parenteral drug injections outside healthcare settings is increasing, driven by the rise of biologic drugs and their biosimilars with compound annual growth rate of 17.6%, for long-term treatments of chronic conditions requiring self-administered subcutaneous injections.
With most patients needing weekly injections, the potential for environmental waste highlights the need for advanced delivery systems. Pharmaceutical companies must focus on auto-injectors that ensure reliability, minimal waste, cost-effectiveness, and ease of use, while also reducing environmental impact and production costs.
E3D is committed to meeting these challenges, offering drug delivery devices designed for reliability, sustainability, and efficiency, enhancing both patient care and environmental responsibility.
Following are 2 devices that represent this commitment
The Flexi-Q mMU is a mechanical, multi-use auto-injector system that combines a reusable device with a single-use cassette containing a drug-filled syringe.
The mMU simplifies the injection process significantly compared to other reusable auto-injectors. Its intuitive “Click ‘n Go” mechanism reduces the traditional 11-step procedure to just 4 handling steps, lowering the risk of errors and making self-injection easier and less stressful.
Adopting E3D’s reusable auto-injector for twice-weekly use over a year allows for replacing 104 standard auto-injectors with one reusable device and 104 disposable cassettes, leading to a 60% reduction in environmental impact and 80% cost savings.
Addressing both patient needs and sustainability goals, the Flexi-Q mMU represents a forward-thinking solution for the future of healthcare
E3D’s Flexi-Q eMU-P is an advanced electro-mechanical multi-use auto-injector system designed for administering drugs in pre-filled syringes. It offers an innovative and sustainable solution for the self-administration of biological drugs, aiming to improve patient care by making it easier, safer, and more efficient.
The Flexi-Q eMU-P integrates a reusable device with a disposable cassette providing the waste and cost savings benefits of multi-use design. Its advanced features bring a host of benefits enhancing treatment safety and efficiency: step-by-step on-screen guidance, full needle protection, and precise dosing, coupled with user-friendly design including advanced connectivity options, enabling seamless data integration.
Flexi-Q eMU-P stands out as a sustainable, state-of-the-art device in modern healthcare.
Elcam offers cost-effective stopcocks with extension tube lines, now additionally available with the innovative Marvelous™ closed needleless minimal residual volume stopcock. These mini-set options can also be fitted with male Luer lock connectors and covers, including the unique Elcam Safe2 Rotator™ connector for additional customization.
These versatile sub-assemblies are available in a variety of configurations to suit the needs of various applications, such as IV lines, introducers, central venous catheters, and pressure monitoring lines.
Elcam’s Stopcock with Extension Tube Line combines convenience and efficiency while upholding the high-quality standards customers expect. With our broad selection of stopcocks and tubes, you can easily tailor your setup to meet your specific requirements.
Invoice fraud is unfortunately quite prevalent and can be difficult to detect. As a result, it often occurs over an extended period, leading to substantial financial losses for businesses—sometimes amounting to thousands, or even millions, of dollars. According to data from the Association of Certified Fraud Examiners (ACFE) in their Occupational Fraud 2022: A Report to the Nations, invoice fraud and similar billing schemes were among the most frequently reported types of asset misappropriation.
At Elcam, we are taking all necessary precautions to prevent such fraud, and we urge our customers to stay vigilant. One of the most effective ways to prevent invoice fraud is to ensure that whenever there is a notification about a change in the recipient’s bank account, it is verified through a video call or a direct phone call. To help raise awareness, we encourage you to explore more about this issue through the link above and the following blog: Invoice Fraud: How to Identify Fake Invoices & More
Igal (Guli) Kohn, CEO and General Manager
22 – 23 January Paris, France Hall 7.2 | Booth H17
4-6 February Anaheim, California Booth 2449
Full Name*
Email*
Company*
Position
Elcam Safety
Elcam Drug Delivery Devices